- Home
- AURA
as 05-30-2025 3:31pm EST
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its lead candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | BOSTON |
| Market Cap: | 370.1M | IPO Year: | 2021 |
| Target Price: | $22.60 | AVG Volume (30 days): | 243.7K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 5 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.90 | EPS Growth: | N/A |
| 52 Week Low/High: | $4.34 - $12.38 | Next Earning Date: | 05-15-2025 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Stock Insider Trading Activity of Aura Biosciences Inc. (AURA)
| Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|---|
| Johnson David Michael | AURA | Director | May 16 '25 | Buy | $4.90 | 20,000 | $98,000.00 | 166,167 | |
| Gibney Anthony S | AURA | See Remarks | May 16 '25 | Buy | $4.90 | 50,000 | $245,000.00 | 58,452 | |
| Gibney Anthony S | AURA | See Remarks | May 16 '25 | Sell | $5.15 | 1,519 | $7,822.85 | 56,933 | |
| Kilroy Conor | AURA | See Remarks | Apr 16 '25 | Sell | $5.49 | 7,162 | $39,319.38 | 179,313 | |
| Elazzouzi Amy | AURA | Senior Vice President, Finance | Apr 16 '25 | Sell | $5.49 | 897 | $4,924.53 | 81,381 |
Latest Aura Biosciences Inc. News
AURA Breaking Stock News: Dive into AURA Ticker-Specific Updates for Smart Investing
MT Newswires
17 days ago
Aura Biosciences Prices $75 Million Offering of Shares, Warrants
GlobeNewswire
17 days ago
Aura Biosciences Announces Pricing of Public Offering of Common Stock and Warrants
MT Newswires
17 days ago
Aura Biosciences Launches Proposed Public Offering of Shares, Warrants
GlobeNewswire
17 days ago
Aura Biosciences Announces Proposed Public Offering of Common Stock and Warrants
GlobeNewswire
17 days ago
Aura Biosciences Reports First Quarter 2025 Financial Results and Business Highlights
GlobeNewswire
a month ago
Aura Biosciences to Participate in Upcoming Investor Conferences
Insider Monkey
2 months ago
Is Aura Biosciences (AURA) The Small Cap Stock with Huge Upside Potential?
GlobeNewswire
2 months ago
Aura Biosciences Announces Appointment of Teresa Bitetti to Board of Directors
Compare AURA vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "AURA Aura Biosciences Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.